Calithera Biosciences, Inc. (NASDAQ:CALA) has 92 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Bristol-Myers BMY receives FDA approval for ozanimod +6% ... Price and Volume Movers Bristol-Myers Squibb Company (NYSE: BMY) announced that the FDA approved Zeposia (ozanimod) for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Sha KPTI - Karyopharm Therapeutics Inc Stock quote - CNNMoney.com
Current Technical Analysis and interactive chart for $IRWD stock / shares. See the current IRWD Ideas on StockTwits · IRWD Tweets on Twitter. Indicators
Cramer: Micron's stock is worth owning over Western Digital's Oct 03, 2018 · CNBC's Jim Cramer breaks down the declines in shares of chipmakers Western Digital and Micron. The "Mad Money" host also explains why he thinks Micron is more valuable. #GoldenCross $IRWD at 13.01 R8 HiLo 99% T1Y 14 buy fwdPE ... Golden Cross detected for IRWD (Ironwood Pharmaceuti) at the close price of 13.01. Trading at a 99 % level between the 52week High (13.06) and 52week Low (7.60). The average analyst 1-year target price is 14.0 with an average buy and a score of 0.0. Golden Cross 8 % IRWD … Breaking News: CLVS latest news. - The Fly
YETI's stock rallies after profit and sales beats, upbeat outlook Shares of YETI Holdings Inc. rallied 2.1% in premarket trading Thursday, after the drinkware and coolers maker reported fourth
Find the latest Cyclerion Therapeutics, Inc. (CYCN) stock quote, history, news and other vital information to help you with your stock trading and investing.
14 Mar 2020 Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Momentum Wrap - Biotech, Drugs and Medical Devices Stocks ... There was a lot more red than green in the momentum universe on Tuesday, which usually foreshadows general market weakness ahead. Many momentum stocks and the indexes in general are in need of some form of consolidation anyway, either through time or price. One thing to pay particular attention to is the change of crowd … Earnings Calendar | StockEarnings.com Since Last Earnings. Change in share price since last Earnings release. Why is it Important? When share has gained more than 10% since it's last Earning release, it tends to over react to minor bad news and give up some gains if not all. CALA / Calithera Biosciences, Inc. - Institutional ... Calithera Biosciences, Inc. (NASDAQ:CALA) has 92 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
View the latest Conatus Pharmaceuticals Inc. (CNAT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Ironwood Pharmaceuticals' Proposed Separation Should Offer ... Aug 10, 2018 · Ironwood Pharmaceuticals is a commercial biotechnology company focused on the treatment of gastrointestinal diseases, abdominal pain, and gout. While Ironwood's
IRWD Chart The Fundamental Chart contains more than 4,000 line items and calculations - from PE Ratios to Payout Ratios - which can be combined to present a clear long-term view of a business. Add to that the ability chart information for multiple companies and multiple metrics at … Ironwood Pharmaceuticals, Inc. - (IRWD) Social Stream Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!